ABBOTT LABORATORIES (ABT)

ABBOTT LABORATORIES (ABT) public financial performance, SEC filing summary, and valuation metrics.

Financial highlights

Contract Revenue: 0 usd (2026-03-31)
Operating Income: 1345000000 usd (2026-03-31)
Net Income: 1077000000 usd (2026-03-31)
Operating Income: 8053000000 usd (2025-12-31)
Net Income: 6524000000 usd (2025-12-31)
Contract Revenue: 0 usd (2025-12-31)
Net Income: 1644000000 usd (2025-09-30)
Contract Revenue: 0 usd (2025-09-30)
Operating Income: 2057000000 usd (2025-09-30)
Net Income: 1779000000 usd (2025-06-30)
Operating Income: 2052000000 usd (2025-06-30)
Contract Revenue: 0 usd (2025-06-30)
Operating Income: 1693000000 usd (2025-03-31)
Contract Revenue: 0 usd (2025-03-31)
Net Income: 1325000000 usd (2025-03-31)
Operating Income: 6825000000 usd (2024-12-31)
Contract Revenue: 0 usd (2024-12-31)
Net Income: 13402000000 usd (2024-12-31)
Operating Income: 1859000000 usd (2024-09-30)
Contract Revenue: 0 usd (2024-09-30)